SU 5205

CAS No. 3476-86-6

SU 5205( SU 5205 | SU-5205 | SU5205 )

Catalog No. M17490 CAS No. 3476-86-6

SU 5205 is a VEGFR2 inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
25MG 28 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    SU 5205
  • Note
    Research use only, not for human use.
  • Brief Description
    SU 5205 is a VEGFR2 inhibitor.
  • Description
    SU 5205 is a VEGFR2 inhibitor.
  • In Vitro
    SU5205 inhibits ligand-induced endothelial mitogenesis for VEGF with an IC50 of 5.1 μM.
  • In Vivo
    ——
  • Synonyms
    SU 5205 | SU-5205 | SU5205
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    VEGFR2
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    3476-86-6
  • Formula Weight
    239.25
  • Molecular Formula
    C15H10FNO
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 250 mg/mL (1044.98 mM)
  • SMILES
    c1ccc2c(c1)/C(=C\c1ccc(cc1)F)/C(=O)N2
  • Chemical Name
    2-Indolinone, 3-(p-fluorobenzylidene)-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Tian XF, et al. PACE4 regulates apoptosis in human pancreatic cancer Panc 1 cells via the mitochondrial signaling pathway. Mol Med Rep. 2016 Dec;14(6):5205-5210.
molnova catalog
related products
  • Ebopiprant

    Ebopiprant (OBE022) is an orally available, selective and potent prostaglandin F2α (PGF2α) receptor antagonist that interferes with the binding of PGF0126α to the FPR and can be used in the study of obesity.

  • Dendronobilin B

    Dendronobilin B is a sesquiterpene compound that can be isolated from Dendrobium crystallinum.

  • Zagotenemab

    Zagotenemab is a humanized antibody against the microtubule-associated protein tau that selectively regulates tau deposits in the brain. Zagotenemab can be used to study neurological disorders such as Alzheimer's disease.